20 Live Notices for Pimecrolimus Tenders
Showing 1 to 20
Completion Of A Non -Exclusive Discount Contract According To Section 130A (8) Sgb V On Medicinal Products With The Active Ingredient Pimecrolimus (Atc: D11Ah02).
04 Mar 2025
25 Feb 2027Completion Of A Non -Exclusive Discount Contract According To Section 130A (8) Sgb V On Medicinal Products With The Active Ingredient Pimecrolimus (Atc: D11Ah02).
Completion Of A Non -Exclusive Discount Contract According To Section 130A (8) Sgb V On Medicinal Products With The Active Ingredient Pimecrolimus (Atc: D11Ah02).
Completion Of A Non -Exclusive Discount Contract According To Section 130A (8) Sgb V On Medicinal Products With The Active Ingredient Pimecrolimus (Atc: D11Ah02).
Conclusion Of Non-Exclusive Discount Agreements According To §130A Para.8 Sgb V For Various Active Ingredients/Combinations With The Possibility Of Conclusion At Any Time Within The Framework Of The So-Called Open House Procedure
Conclusion Of Non-Exclusive Discount Agreements According To §130A Para.8 Sgb V For Various Active Ingredients/Combinations With The Possibility Of Conclusion At Any Time Within The Framework Of The So-Called Open House Procedure
Conclusion Of Non-Exclusive Discount Agreements According To §130A Para.8 Sgb V For Various Active Ingredients/Combinations With The Possibility Of Conclusion At Any Time Within The Framework Of The So-Called Open House Procedure
Conclusion Of Non-Exclusive Discount Agreements According To §130A Para.8 Sgb V For Various Active Ingredients/Combinations With The Possibility Of Conclusion At Any Time Within The Framework Of The So-Called Open House Procedure
Open House Drug Discount Agreements Pimecrolimus, Atc D11Ah02
Open House Drug Discount Agreements Pimecrolimus, Atc D11Ah02
Conclusion Of Non-Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Pimecrolimus (D11Ah02) As Part Of A So-Called Open House Model.
Conclusion Of Non-Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Pimecrolimus (D11Ah02) As Part Of A So-Called Open House Model.
Open House Contracts For Multiple Active Ingredients/Active Ingredient Combinations
Open House Contracts For Multiple Active Ingredients/Active Ingredient Combinations
Open House Contracts For Multiple Active Ingredients/Active Ingredient Combinations
Open House Contracts For Multiple Active Ingredients/Active Ingredient Combinations
Pimecrolimus Creme Ba1.13.B
Pimecrolimus Creme Ba1.13.B
Ung Pimecrolimus 1 Percent 10Gm , Lot Tacrolimus 0 Point 1Percent Bott Of 20 Ml , Fenticonazole Cream 30 Gm , Retinol0 Point 15 Percent Eyeseryl 1 Percent Phytonadione 1Percent Cream Tube Of 15 Gm , Tacrolimus 0 Point 1 Percentoral Gel 25Ml , Salemeterol 50 Mcg Plus Fluticasone 125 Mgmdi 120 Doses , Salemeterol 50 Mcg Plus Fluticasone 250Mg Mdi 120 Doses , Rabies Immunoglobulin Humanmonoclonal Antibody 40 Iu Ml Vial Of 2.5 Ml , Factor Viii 500Iu Inj , Inj Insulin Analogue Rapid Acting Recombinant Dnaorigin 100 Iuml Pfs Of 3 Ml , Propylene Glycol Pluscyclomethicone Plus Emulisfying Wax Plus Glycerin Lotion Of300 Ml , Zinc Oxide Plus Dimethicone Crosspolymer Pluspolyhdroxystearic Acid Spf 50 Jar Of 50 Gm , Otinoxate Plusglycolic Acid Plus Kojic Acid Plus Arbutin Plus Tocopherylacetate Tube Of 30Mg , Hep A Vaccine Quantity: 9065
Ung Pimecrolimus 1 Percent 10Gm , Lot Tacrolimus 0 Point 1Percent Bott Of 20 Ml , Fenticonazole Cream 30 Gm , Retinol0 Point 15 Percent Eyeseryl 1 Percent Phytonadione 1Percent Cream Tube Of 15 Gm , Tacrolimus 0 Point 1 Percentoral Gel 25Ml , Salemeterol 50 Mcg Plus Fluticasone 125 Mgmdi 120 Doses , Salemeterol 50 Mcg Plus Fluticasone 250Mg Mdi 120 Doses , Rabies Immunoglobulin Humanmonoclonal Antibody 40 Iu Ml Vial Of 2.5 Ml , Factor Viii 500Iu Inj , Inj Insulin Analogue Rapid Acting Recombinant Dnaorigin 100 Iuml Pfs Of 3 Ml , Propylene Glycol Pluscyclomethicone Plus Emulisfying Wax Plus Glycerin Lotion Of300 Ml , Zinc Oxide Plus Dimethicone Crosspolymer Pluspolyhdroxystearic Acid Spf 50 Jar Of 50 Gm , Otinoxate Plusglycolic Acid Plus Kojic Acid Plus Arbutin Plus Tocopherylacetate Tube Of 30Mg , Hep A Vaccine Quantity: 9065
Tenders by Country